ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 218 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $499,000 | -52.3% | 35,948 | -3.6% | 0.00% | -50.0% |
| Q4 2021 | $1,047,000 | -23.8% | 37,306 | -7.8% | 0.00% | -50.0% |
| Q3 2021 | $1,374,000 | -17.9% | 40,450 | -1.2% | 0.00% | 0.0% |
| Q2 2021 | $1,674,000 | -5.2% | 40,957 | -6.6% | 0.00% | -20.0% |
| Q1 2021 | $1,765,000 | -61.8% | 43,850 | -43.9% | 0.01% | -58.3% |
| Q4 2020 | $4,620,000 | +27.4% | 78,134 | +4.8% | 0.01% | +9.1% |
| Q3 2020 | $3,626,000 | +17.0% | 74,565 | +16.4% | 0.01% | +10.0% |
| Q2 2020 | $3,100,000 | – | 64,080 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $23,152,516 | 15.55% |
| BERYLSON CAPITAL PARTNERS, LLC | 289,726 | $2,213,507 | 6.45% |
| Matrix Capital Management Company, LP | 11,572,590 | $88,414,588 | 1.69% |
| Pier Capital, LLC | 1,012,401 | $7,734,744 | 1.27% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $229,151,929 | 1.15% |
| Eagle Health Investments LP | 607,860 | $4,644,050 | 1.07% |
| Triatomic Management LP | 130,805 | $999,350 | 0.84% |
| Aristotle Atlantic Partners, LLC | 1,880,567 | $14,367,532 | 0.80% |
| Senator Investment Group LP | 1,000,000 | $7,640,000 | 0.69% |
| ARK Investment Management | 9,201,245 | $70,297,512 | 0.61% |